awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26786618-0A91722F-6918-4F15-B5A7-8E5FE281ABEE
Q26786618-0A91722F-6918-4F15-B5A7-8E5FE281ABEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786618-0A91722F-6918-4F15-B5A7-8E5FE281ABEE
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
P2860
Q26786618-0A91722F-6918-4F15-B5A7-8E5FE281ABEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786618-0A91722F-6918-4F15-B5A7-8E5FE281ABEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54f6c0ec189e45d089132377e86eda71e70ed37a
P2860
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206